TAG:
reference laboratories
HDL Founders, BlueWave, Shareholders Sued for $600 Million by Bankruptcy Trustee
By Joseph Burns | From the Volume XXIII No. 13 – September 26, 2016 Issue
CEO SUMMARY: Unlike federal prosecutors, who to date have shown little interest in seeking to recover money from either the physicians who accepted inducements from Health Diagnostic Laboratory or many of the shareholders, executives, and sales consultants of HDL, the trustee of the HDL b…
At Executive War College 2016, Two Big Lab Market Trends
By Robert Michel | From the Volume XXIII No. 6 – May 2, 2016 Issue
CEO SUMMARY: What happens when 100 lab experts interact with an audience of more than 850 lab administrators, pathologists, and IVD executives from across the United States and seven other nations? A consensus of sorts emerges and during this 2016 edition of the Executive War College on L…
UnitedHealthcare Warns Labs: Don’t Waive Patient Fees
By Joseph Burns | From the Volume XXIII No. 4 – March 21, 2016 Issue
This article is an excerpt from a 1,500-word article in the March 21 issue of THE DARK REPORT. Full details of UHC’s battle against out-of-network labs, as well as its plans to begin requiring pre-authorization for genetic testing, are included in the original article, available to paid members…
A Pantheon of Greatest Lab Physician-Businessmen
By R. Lewis Dark | From the Volume XXIII No. 4 – March 21, 2016 Issue
WHEN IT COMES TO THE CLINICAL LABORATORY BUSINESS, generally included in the lab industry’s Pantheon of Greatest Physician (Pathologist) Businessmen are Paul A. Brown, MD, and James B. Powell, MD. I’d like to nominate another physician to this list: Marc D. Grodman, MD. During the 1970s and 1980…
Grodman Resigns from BRLI, New President Is Henderson
By Joseph Burns | From the Volume XXIII No. 4 – March 21, 2016 Issue
THERE IS A NEW LEADER at Bio-Reference Laboratories, Inc., now owned by OPKO Health, Inc., of Miami, Florida. Last week, Gregory Henderson, MD, PhD, was named as President of BRLI. Henderson takes over from Marc Grodman, MD, who resigned after serving as Chairman, P…
UnitedHealthcare Warns Labs Not to Waive Patient Fees
By Joseph Burns | From the Volume XXIII No. 4 – March 21, 2016 Issue
CEO SUMMARY: UnitedHealthcare directly tackled the issue of out-of-network labs waiving or capping copayments, coinsurance and deductibles that are to be paid by patients. In a network bulletin this month, UHC said that such arrangements may violate federal law and could lead to state ins…
March 21, 2016 Intelligence: Late Breaking Lab News
By Robert Michel | From the Volume XXIII No. 4 – March 21, 2016 Issue
Tougher times in the clinical lab testing market have claimed another lab company. On February 28, Artherotech, Inc., posted a notice on its website stating that it had closed permanently, as of that date. Along with its several hundred employees, Artherotech’s closure caught many…
December 28, 2015 Intelligence: Late Breaking Lab News
By Robert Michel | From the Volume XXII, Number 18 – December 28, 2015 Issue
To advance the practice of precision medicine through better use of genetic testing, a new limited liability corporation (LLC) was formed. Participating in the LLC are North Shore-LIJ Heal…
TriCore Reference Labs Adds Value With Consults, Better TAT – June 17, 2013
By R. Lewis Dark | From the Volume XX No. 8 – June 17, 2013 Issue
CEO SUMMARY: Motivated by the goal of delivering more value to clinicians and client hospitals, the lab team at TriCore Reference Laboratories in Albuquerque, New Mexico, is proactively introducing new s…
Opko Pays $1.47 Billion to Buy Bio-Reference Lab
By Robert Michel | From the Volume XXII NO. 9 – June 22, 2015 Issue
CEO SUMMARY: It’s a case of the little fish gobbling the big fish, as Opko Health – with revenue of $91 million – will be acquiring Bio-Reference Laboratories, with revenue of $832 million. But the more interesting aspect of the story is that the CEO of Opko Health is a physi…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized